Paper33192068
Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema.
Giarmoukakis AK and 6 others. Ther Clin Risk Manag, 2020. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema. Papers, record 33192068. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33192068
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28268098 | Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies. | Ophthalmology | 2017 | https://conductscience.org/library/papers/28268098 | PubMed |
| 2 | 17720067 | In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. | J Cataract Refract Surg | 2007 | https://conductscience.org/library/papers/17720067 | PubMed |
| 3 | 22927737 | Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. | Clin Ophthalmol | 2012 | https://conductscience.org/library/papers/22927737 | PubMed |
| 4 | 14709300 | Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac. | J Cataract Refract Surg | 2003 | https://conductscience.org/library/papers/14709300 | PubMed |
| 5 | 28351047 | Postsurgical Cystoid Macular Edema. | Dev Ophthalmol | 2017 | https://conductscience.org/library/papers/28351047 | PubMed |
| 6 | 29269999 | Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives. | Clin Ophthalmol | 2017 | https://conductscience.org/library/papers/29269999 | PubMed |
| 7 | 18988178 | Pseudophakic macular edema and oral acetazolamide: an optical coherence tomography measurable, dose-related response. | Eur J Ophthalmol | 2008 | https://conductscience.org/library/papers/18988178 | PubMed |
| 8 | 20175270 | NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. | Retina | 2010 | https://conductscience.org/library/papers/20175270 | PubMed |
| 9 | 22440164 | Evaluation of cystoid macular edema using optical coherence tomography and fundus fluorescein angiography after uncomplicated phacoemulsification surgery. | Curr Eye Res | 2012 | https://conductscience.org/library/papers/22440164 | PubMed |
| 10 | 25285465 | Reliability of intravitreal nepafenac in rabbits. | J Ocul Pharmacol Ther | 2015 | https://conductscience.org/library/papers/25285465 | PubMed |
| 11 | 655537 | Route of absorption of drug and ointment after application to the eye. | Ann Ophthalmol | 1978 | https://conductscience.org/library/papers/655537 | PubMed |
| 12 | 20703048 | Postsurgical cystoid macular edema. | Dev Ophthalmol | 2010 | https://conductscience.org/library/papers/20703048 | PubMed |
| 13 | 19639332 | Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy. | Graefes Arch Clin Exp Ophthalmol | 2009 | https://conductscience.org/library/papers/19639332 | PubMed |
| 14 | 5964923 | Fluorescein studies of patients with macular edema and papilledema following cataract extraction. | Trans Am Ophthalmol Soc | 1966 | https://conductscience.org/library/papers/5964923 | PubMed |
| 15 | 27388251 | Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy. | Br J Ophthalmol | 2017 | https://conductscience.org/library/papers/27388251 | PubMed |
| 16 | 785652 | Cystoid maculopathy. | Surv Ophthalmol | 1976 | https://conductscience.org/library/papers/785652 | PubMed |
| 17 | 26681390 | Risk Factors and Incidence of Macular Edema after Cataract Surgery: A Database Study of 81984 Eyes. | Ophthalmology | 2016 | https://conductscience.org/library/papers/26681390 | PubMed |
| 18 | 26474497 | Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye. | Exp Eye Res | 2016 | https://conductscience.org/library/papers/26474497 | PubMed |
| 19 | 10189253 | Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. | J Pharm Sci | 1998 | https://conductscience.org/library/papers/10189253 | PubMed |
| 20 | 18001248 | Cystoid and diabetic macular edema treated with nepafenac 0.1%. | J Ocul Pharmacol Ther | 2007 | https://conductscience.org/library/papers/18001248 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42271301 | Comparison of topical nepafenac 0.1% and 0.3% for the treatment of pseudophakic cystoid macular edema following cataract surgery. | BMC Ophthalmol | 2026 | https://conductscience.org/library/papers/42271301 | PubMed |
| 41209449 | A Case of Corneal Melting Associated with Topical Diclofenac After Phacovitrectomy for Macular Pucker in a Patient with Rheumatoid Arthritis. | Int Med Case Rep J | 2025 | https://conductscience.org/library/papers/41209449 | PubMed |
| 41003131 | Irvine-Gass Syndrome Personalized Treatment Outcomes: A Retrospective Single-Center Cohort Study. | J Pers Med | 2025 | https://conductscience.org/library/papers/41003131 | PubMed |
| 38274400 | Navigated yellow subthreshold micropulse laser for refractory cystoid macular edema following rhegmatogenous retinal detachment surgery. | Am J Ophthalmol Case Rep | 2024 | https://conductscience.org/library/papers/38274400 | PubMed |
| 34640393 | Current Management Options in Irvine-Gass Syndrome: A Systemized Review. | J Clin Med | 2021 | https://conductscience.org/library/papers/34640393 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33192068
GET https://conductscience.org/api/papers/v1/33192068/references?page=2